Since the recognition that Parkinson's disease is associated with dopamine depletion in the caudate and putamen and cell loss in the substantia nigra, there has been steady progress in understanding the role of dopamine in movement disorders. L-dopa therapy has offered partial relief by increasing brain dopamine and relieving symptoms in the Parkinsonian patient. However after several years of disease, drug therapy becomes less effective with patients often showing a more brittle response. Transplantation-of fetal mesencephalic dopamine cells may be able to restore motor function and drug responsiveness to the Parkinson patient-. Human fetal dopamine cell transplants are already being tested in patients. This grant proposal will address several questions designed to improve the effectiveness of fetal cell implants in rat models of Parkinson's disease. In rodent and primate experiments, fetal dopamine cell implants have been shown to have behavioral effects. Despite clear evidence that fetal mesencephalic dopamine neurons can survive and grow neurites in striatum and can influence amphetamine and apomorphine behaviors, there are few experiments showing that transplants alter spontaneous motor activity or are functionally activated during voluntary motor behavior. Previous experiments by us have shown that animals trained to run in circles for a water reward show increased dopamine metabolism in a number of brain nuclei, increased firing of dopamine cells in substantia nigra pars compacta, and increased firing in striatal neurons during movement. The present experiments will examine whether rats with unilateral dopamine depletion followed by dopamine cell implants in striatum have movement related activation of dopamine cell firing in the implant, dopamine release from the striatum and changes in striatal and pallidal cell firing. Studies of movement related release of dopamine will be done by in vivo dialysis. Electrophysiological studies of nigral, striatal and pallidal cell firing will also be performed in the moving animal.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS018639-08
Application #
3398655
Study Section
Neurology B Subcommittee 2 (NEUB)
Project Start
1983-04-01
Project End
1995-08-31
Budget Start
1992-09-01
Budget End
1993-08-31
Support Year
8
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Zhou, Wenbo; Schaack, Jerome; Zawada, W Michael et al. (2002) Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture. Brain Res 926:42-50
Veng, Lone M; Bjugstad, Kimberly B; Freed, Curt R et al. (2002) Xenografts of MHC-deficient mouse embryonic mesencephalon improve behavioral recovery in hemiparkinsonian rats. Cell Transplant 11:5-16
Bjugstad, K B; Zawada, W M; Goodman, S et al. (2001) IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures. J Inherit Metab Dis 24:631-47
Zawada, W M; Meintzer, M K; Rao, P et al. (2001) Inhibitors of p38 MAP kinase increase the survival of transplanted dopamine neurons. Brain Res 891:185-96
Clarkson, E D; Zawada, W M; Bell, K P et al. (2001) IGF-I and bFGF improve dopamine neuron survival and behavioral outcome in parkinsonian rats receiving cultured human fetal tissue strands. Exp Neurol 168:183-91
Kaddis, F G; Clarkson, E D; Bell, K P et al. (2000) Co-grafts of muscle cells and mesencephalic tissue into hemiparkinsonian rats: behavioral and histochemical effects. Brain Res Bull 51:203-11
Zhou, W; Hurlbert, M S; Schaack, J et al. (2000) Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res 866:33-43
Hurlbert, M S; Zhou, W; Wasmeier, C et al. (1999) Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes 48:649-51
Clarkson, E D; Edwards-Prasad, J; Freed, C R et al. (1999) Immortalized dopamine neurons: A model to study neurotoxicity and neuroprotection. Proc Soc Exp Biol Med 222:157-63
Hurlbert, M S; Gianani, R I; Hutt, C et al. (1999) Neural transplantation of hNT neurons for Huntington's disease. Cell Transplant 8:143-51

Showing the most recent 10 out of 41 publications